These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 26348473)

  • 1. Biosynthesis of 3-Iodothyronamine From T4 in Murine Intestinal Tissue.
    Hoefig CS; Wuensch T; Rijntjes E; Lehmphul I; Daniel H; Schweizer U; Mittag J; Köhrle J
    Endocrinology; 2015 Nov; 156(11):4356-64. PubMed ID: 26348473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biosynthesis of 3-iodothyronamine (T1AM) is dependent on the sodium-iodide symporter and thyroperoxidase but does not involve extrathyroidal metabolism of T4.
    Hackenmueller SA; Marchini M; Saba A; Zucchi R; Scanlan TS
    Endocrinology; 2012 Nov; 153(11):5659-67. PubMed ID: 22948220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyronamines and Derivatives: Physiological Relevance, Pharmacological Actions, and Future Research Directions.
    Hoefig CS; Zucchi R; Köhrle J
    Thyroid; 2016 Dec; 26(12):1656-1673. PubMed ID: 27650974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating 3-T1AM and 3,5-T2 in Critically Ill Patients: A Cross-Sectional Observational Study.
    Langouche L; Lehmphul I; Perre SV; Köhrle J; Van den Berghe G
    Thyroid; 2016 Dec; 26(12):1674-1680. PubMed ID: 27676423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In the brain of mice, 3-iodothyronamine (T1AM) is converted into 3-iodothyroacetic acid (TA1) and it is included within the signaling network connecting thyroid hormone metabolites with histamine.
    Laurino A; De Siena G; Saba A; Chiellini G; Landucci E; Zucchi R; Raimondi L
    Eur J Pharmacol; 2015 Aug; 761():130-4. PubMed ID: 25941083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Combined Levothyroxine (L-T
    Rutigliano G; Bertolini A; Grittani N; Frascarelli S; Carnicelli V; Ippolito C; Moscato S; Mattii L; Kusmic C; Saba A; Origlia N; Zucchi R
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uptake and metabolic effects of 3-iodothyronamine in hepatocytes.
    Ghelardoni S; Chiellini G; Frascarelli S; Saba A; Zucchi R
    J Endocrinol; 2014 Apr; 221(1):101-10. PubMed ID: 24627446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outer and inner ring monodeiodination of thyroxine by dog thyroid and liver: a comparative study using a particulate cell fraction.
    Laurberg P; Boye N
    Endocrinology; 1982 Jun; 110(6):2124-30. PubMed ID: 7075551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3-Iodothyronamine reduces insulin secretion in vitro via a mitochondrial mechanism.
    Lehmphul I; Hoefig CS; Köhrle J
    Mol Cell Endocrinol; 2018 Jan; 460():219-228. PubMed ID: 28754352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological effects of 3-iodothyronamine (T1AM) in mice include facilitation of memory acquisition and retention and reduction of pain threshold.
    Manni ME; De Siena G; Saba A; Marchini M; Landucci E; Gerace E; Zazzeri M; Musilli C; Pellegrini-Giampietro D; Matucci R; Zucchi R; Raimondi L
    Br J Pharmacol; 2013 Jan; 168(2):354-62. PubMed ID: 22889145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does the aromatic L-amino acid decarboxylase contribute to thyronamine biosynthesis?
    Hoefig CS; Renko K; Piehl S; Scanlan TS; Bertoldi M; Opladen T; Hoffmann GF; Klein J; Blankenstein O; Schweizer U; Köhrle J
    Mol Cell Endocrinol; 2012 Feb; 349(2):195-201. PubMed ID: 22061622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of 3-iodothyronamine (3-T
    Li ZM; Miller M; Gachkar S; Mittag J; Schriever SC; Pfluger PT; Schramm KW; De Angelis M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Feb; 1165():122553. PubMed ID: 33503577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rat enterohepatic circulation and intestinal distribution of enterally infused thyroid hormones.
    DiStefano JJ; Sternlicht M; Harris DR
    Endocrinology; 1988 Nov; 123(5):2526-39. PubMed ID: 3168933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel thyroid hormones.
    Zucchi R; Rutigliano G; Saponaro F
    Endocrine; 2019 Oct; 66(1):95-104. PubMed ID: 31327156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered thyroidal responsivity to thyrotropin induced by circulating thyroid hormones. A "short-loop" regulatory mechanism?
    Yu S; Friedman Y; Richman R; Burke G
    J Clin Invest; 1976 Mar; 57(3):745-55. PubMed ID: 175094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential deiodination of thyroxine in human thyroid gland.
    Ishii H; Inada M; Tanaka K; Mashio Y; Naito K; Nishikawa M; Matsuzuka F; Kuma K; Imura H
    J Clin Endocrinol Metab; 1982 Nov; 55(5):890-6. PubMed ID: 6896880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fasting-induced increase in type II iodothyronine deiodinase activity and messenger ribonucleic acid levels is not reversed by thyroxine in the rat hypothalamus.
    Diano S; Naftolin F; Goglia F; Horvath TL
    Endocrinology; 1998 Jun; 139(6):2879-84. PubMed ID: 9607797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyronamines are isozyme-specific substrates of deiodinases.
    Piehl S; Heberer T; Balizs G; Scanlan TS; Smits R; Koksch B; Köhrle J
    Endocrinology; 2008 Jun; 149(6):3037-45. PubMed ID: 18339710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue distribution and cardiac metabolism of 3-iodothyronamine.
    Saba A; Chiellini G; Frascarelli S; Marchini M; Ghelardoni S; Raffaelli A; Tonacchera M; Vitti P; Scanlan TS; Zucchi R
    Endocrinology; 2010 Oct; 151(10):5063-73. PubMed ID: 20739399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iodothyronine deiodinase activities in FRTL5 cells: predominance of type I 5'-deiodinase.
    Borges M; Ingbar SH; Silva JE
    Endocrinology; 1990 Jun; 126(6):3059-68. PubMed ID: 2351108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.